FOLH1 and prostate cancer: We describe the construction of a prostate specific membrane antigen (PSMA) binding bioconjugate-polyplex, using ‘click’ chemistry, which we demonstrate is capable of targeted delivery of a GFP gene to PSMA overexpressing prostate cancer cells.